NCT01607346 An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures Status TERMINATED Phase PHASE4
NCT01607333 WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide Status COMPLETED Phase N/A
NCT01590862 ON/OFF Stimulation and Reward Motivation in Patients With Deep Brain Stimulators Status COMPLETED Phase NA
NCT01587339 Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy Status COMPLETED Phase N/A
NCT01583036 An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed Status COMPLETED Phase PHASE1
NCT01576601 The Management of Postoperative Craniotomy Pain in Pediatric Patients Status COMPLETED Phase N/A
NCT01563627 Serum Profile of Inflammatory Factors, Immune and Angiogenic in Temporal Lobe Epilepsy Status COMPLETED Phase NA
NCT01550874 STEP: Enhanced Physical Activity in Children and Youth With Epilepsy Status COMPLETED Phase NA
NCT01546688 A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures Status TERMINATED Phase PHASE4
NCT01532726 Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA) Status COMPLETED Phase N/A
NCT01529034 Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters Status TERMINATED Phase PHASE3
NCT01515436 The Effect of Music Periodicity on Interictal Epileptiform Discharges Status COMPLETED Phase NA
NCT01506882 An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy Status COMPLETED Phase PHASE3
NCT01501383 A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy Status TERMINATED Phase PHASE2
NCT01498822 Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy Status COMPLETED Phase PHASE4